Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody…
Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional…
Read More...
Read More...
